Germany Compression Therapy Market Report 2022 to 2030

Germany Compression Therapy Market Analysis

$ 3999

Germany Compression Therapy Market was valued at $139 Mn in 2022 and is estimated to reach $187 Mn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The increase in the occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a crucial factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Medi, Sigvaris, Juzo, Jobst, Bauerfeind, Bauer Health GmbH, Orthopädische Industrie Herbst GmbH & Co. KG, DJO Global, FLA Orthopedics and Thuasne.

ID: IN10DEPH311 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Medha Sansanwal

Buy Now

Germany Compression Therapy Market Executive Summary

Germany Compression Therapy Market was valued at $139 Mn in 2022 and is estimated to reach $187 Mn in 2030, exhibiting a CAGR of 3.8% during the forecast period.

Compression therapy is a medical procedure commonly utilized on limbs to enhance blood circulation and reduce swelling. It is often employed in the treatment of conditions like lymphedema, venous disorders, and certain types of edemas. The primary objective is to enhance the flow of blood in the veins, facilitating the return of blood to the heart. This helps prevent the accumulation of fluid in the tissues, especially when swelling is a result of fluid retention. Depending on the severity of the condition and the individual's specific needs, compression therapy can take various forms, such as elastic stockings, sleeves, or bandages. Techniques like compression wraps involve the use of multiple layers of bandages to provide graduated compression, while intermittent pneumatic compression (IPC) employs a device to mimic natural muscle contractions, assisting in venous return. To determine the most suitable technique and compression level for a particular case, it is essential to consult with a healthcare provider, especially when developing comprehensive treatment plans for issues like poor circulation, swelling, or fluid retention.

Chronic venous insufficiency (CVI) is prevalent in 20-25% of the adult German population, with varicose veins affecting 20-40% of adults, particularly impacting women. Pregnancy, obesity, and jobs requiring extended standing are risk factors for varicose veins. Every 1,000 people, there are 1-2 cases of deep vein thrombosis (DVT) each year. Lifestyle factors like increased obesity rates, prolonged sitting and standing, and little physical activity all contribute to these prevalence rates. Genetics also play a role, with certain populations having a higher genetic predisposition. An additional factor raising a person's risk is a family history of vein problems. Notably, women who are pregnant are more likely to experience vein issues.

Recently, a multi-component compression system that is integrated into a single bandage has shown promise in reducing edema, improving health-related quality of life, and healing venous leg ulcers more quickly. It has also shown high levels of acceptance and tolerance. This ground-breaking system presents itself as a viable substitute for the compression systems that are currently on the market, giving patients better acceptance and comfort while providing a comprehensive approach to the treatment of venous leg ulcers.

Market Dynamics

Market Growth Drivers

Aging Population: The increasing proportion of the population aged 65 and above in Germany, currently at 21.1% and expected to reach 32.2% by 2050, serves as a significant growth driver for the compression therapy market. With women comprising over half (53.9%) of this demographic, there is a substantial market opportunity. The elevated prevalence of venous disorders and lymphedema among the elderly population is a primary factor fuelling the demand for compression therapy products, thereby stimulating market expansion.

Prevalence of Chronic Diseases: Around 60% of people in Germany are overweight or obese, which is a significant factor driving the market for compression therapy. This group drives the market's expansion by adding to the need for compression therapy in the treatment of ailments like deep vein thrombosis and venous ulcers linked to diseases related to obesity.

Awareness and Education: One of the main factors driving the expansion of the compression therapy market is the growing recognition of the advantages of compression therapy among patients and medical professionals. There is a greater acceptance of compression therapy as awareness grows, which raises the demand for these products. This increased demand plays a major role in the market's overall growth in Germany.

Market Restraints

Inconsistent Patient Adherence: Accurate and consistent adherence to recommended usage is essential for the effectiveness of compression therapy. The efficacy of the therapy may be lowered by patient deviation from advised usage schedules, which could impede the expansion of the compression therapy market. As it may jeopardize therapeutic outcomes and thereby reduce overall market demand, inconsistent patient adherence acts as a restraint on the market.

Cost Barriers: The high costs associated with compression therapy products act as a restraint on the growth of the market. This is mainly attributed to the potential limitation of accessibility, particularly for individuals with lower income levels, making it challenging for them to afford these products. Consequently, the elevated expenses serve as a barrier, obstructing the widespread adoption of compression therapy and constraining the market from expanding.

Inconvenience and Discomfort: The discomfort or inconvenience experienced by certain individuals when wearing compression garments can result in non-compliance and a decreased willingness to integrate compression therapy into their daily routine. This becomes a market restraint as it hinders widespread acceptance and usage of compression therapy, impacting the overall growth of the market.

Healthcare Policies and Regulatory Landscape

In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) and the Paul-Ehrlich-Institute (PEI) play key roles in healthcare policies and regulatory oversight for treatment drugs. The Ministry of Health's BfArM is in charge of assessing and approving medications for the German market to guarantee their efficacy, safety, and quality. Another regulatory body that focuses on vaccines and advanced therapies is the PEI. Germany promotes a coordinated approach within the European Union by adhering to the regulations set forth by the European Medicines Agency (EMA). Furthermore, the effectiveness and cost-effectiveness of pharmaceuticals are evaluated by the Institute for Quality and Efficiency in Health Care (IQWiG). In general, Germany's healthcare policies seek to create a strong regulatory framework to protect public health while promoting medical advancements, striking a balance between granting access to cutting-edge treatments and keeping costs under control.

Competitive Landscape

Key Players

Medi
Sigvaris
Juzo
Jobst
Bauerfeind
Bauer Health GmbH
Orthopädische Industrie Herbst GmbH & Co. KG
DJO Global
FLA Orthopedics
Thuasne

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Compression Therapy Market Segmentation

By Product

Compression Bandages
Compression Wraps
Compression Stockings
Compression Tapes
Compression Pumps
Compression Braces
Other Compression Garments

By Technique

Static Compression Therapy
Dynamic Compression Therapy

By Application

Varicose Vein Treatment
Deep Vein Thrombosis Treatment
Lymphedema Treatment
Leg Ulcer Treatment
Other Applications

By Distribution Channel

Pharmacies and Retailers
Hospitals and Clinics
E-Commerce Platforms
Home Care Settings

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.